[1] |
王晓红, 王海生, 田沙沙, 等. 老年高血压患者全身麻醉诱导和维持中依托咪酯与丙泊酚应用的临床观察[J]. 中国药物与临床, 2014, 14(10): 1421-1422.
|
[2] |
Forman SA. Clinical and molecular pharmacology of etomidate[J]. Anesthesiology,2011, 114(6): 695-707.
|
[3] |
徐进, 李平, 周彤, 等. 不同剂量舒芬太尼抑制依托咪酯引起肌震颤反应的比较[J]. 中国临床药理学杂志, 2013, 29(10): 789-790.
|
[4] |
王炎, 夏晓琼, 张庆, 等. 不同剂量布托啡诺预防舒芬太尼诱发呛咳的临床观察[J]. 中华麻醉学杂志, 2015, 31(11): 1124-1125.
|
[5] |
Zhang J, Miao S, Tu Q, et al. Effect of butorphanol on opioid-induced cough: a meta-analysis of randomized controlled trials[J]. Drug Des Devel Ther, 2018, 12: 3263-3268.
|
[6] |
Nagalakshmi P, Leo S, Uthirapathi S, et al. Use of butorphanol, fentanyl, and ketamine as co-induction agents with propofol for laryngeal mask airway insertion: A comparative study[J]. Anesth Essays Res, 2018, 12(3): 729-734.
|
[7] |
武毅彬, 朱毅, 金星, 等. 舒芬太尼复合依托咪酯麻醉诱导的适宜剂量[J]. 临床麻醉学杂志, 2011, 27(11): 1122-1123.
|
[8] |
刘莹, 高洋, 石景辉, 等. 舒芬太尼诱发呛咳反应的研究进展[J]. 现代医学, 2018, 46(3): 361-363.
|
[9] |
黄宇光, 黄文起, 李刚, 等. 酒石酸布托啡诺镇痛专家共识[J]. 临床麻醉学杂志, 2011, 27(10): 1028-1029.
|
[10] |
陈颖洁, 黄绍强. 布托啡诺与舒芬太尼镇痛效应的相互作用[J]. 中华麻醉学杂志, 2017, 37(8): 975-976.
|
[11] |
Manocha A, Sharma KK, Mediratta PK. Possible mechanism involved in the anticonvulsant action of butorphanol in mice[J]. Pharmacol Biochem and Behav, 2003, 74(2): 343-350.
|
[12] |
张婧, 刘玲, 刘和平, 等. 布托啡诺、咪达唑仑单独或复合用药预防麻醉诱导时依托咪酯诱发患者肌阵挛效果的比较[J]. 中华麻醉学杂志, 2015, 35(11): 1325-1326.
|
[13] |
Sun ZT, Yang CY, Cui Z, et al. Effect of intravenous dezocine on fentanyl-induced cough during general anesthesia induction: a double-blinded, prospective, randomized, controlled trial[J]. J Anesth, 2011, 25(6): 860-863.
|